Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 235.20
-0.40 (-0.17%)
Jul 24, 2026, 5:29 PM CET
Xvivo Perfusion AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,409 | 5,878 | 15,403 | 10,379 | 5,459 | 8,215 | |
Market Cap Growth | 7.99% | -61.84% | 48.41% | 90.12% | -33.55% | -8.90% |
Enterprise Value | 7,225 | 5,710 | 15,022 | 9,864 | 5,223 | 7,822 |
Last Close Price | 235.20 | 186.60 | 489.00 | 329.50 | 183.00 | 278.50 |
PE Ratio | 83.65 | 233.25 | 89.89 | 107.33 | 295.16 | 994.64 |
Forward PE | 47.73 | 51.19 | 92.61 | 199.34 | 111.93 | 211.39 |
PEG Ratio | - | 3.51 | 3.51 | 3.51 | 3.51 | - |
PS Ratio | 8.28 | 7.24 | 18.73 | 17.37 | 13.15 | 31.80 |
PB Ratio | 3.37 | 2.78 | 7.14 | 5.34 | 3.82 | 6.39 |
P/TBV Ratio | 11.60 | 8.88 | 20.65 | 13.61 | 21.46 | 22.38 |
P/FCF Ratio | 42.89 | 800.25 | 379.77 | 3172.09 | 564.50 | - |
P/OCF Ratio | 31.35 | 58.16 | 138.41 | 224.23 | 195.98 | - |
EV/Sales Ratio | 8.07 | 7.03 | 18.27 | 16.51 | 12.58 | 30.27 |
EV/EBITDA Ratio | 64.71 | 64.61 | 170.02 | 2355.96 | 814.90 | - |
EV/EBIT Ratio | 64.71 | 64.61 | 170.02 | 2355.96 | 814.90 | - |
EV/FCF Ratio | 41.83 | 777.46 | 370.37 | 3014.80 | 540.04 | - |
Debt / Equity Ratio | 0.05 | 0.05 | 0.01 | 0.01 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 1.09 | 1.41 | 0.39 | 7.51 | 1.56 | - |
Debt / FCF Ratio | 0.52 | 16.98 | 0.84 | 9.61 | 1.03 | - |
Net Debt / Equity Ratio | -0.08 | -0.08 | -0.18 | -0.26 | -0.16 | -0.31 |
Net Debt / EBITDA Ratio | -1.64 | -1.89 | -4.32 | -122.92 | -36.91 | 21.24 |
Net Debt / FCF Ratio | -0.78 | -22.79 | -9.41 | -157.29 | -24.46 | 17.66 |
Asset Turnover | 0.37 | 0.34 | 0.36 | 0.30 | 0.25 | 0.19 |
Inventory Turnover | 1.04 | 0.89 | 1.12 | 1.23 | 1.29 | 1.02 |
Quick Ratio | 2.65 | 3.68 | 3.14 | 4.94 | 2.60 | 4.43 |
Current Ratio | 3.86 | 5.77 | 4.58 | 6.14 | 3.47 | 5.24 |
Return on Equity (ROE) | 4.11% | 1.18% | 8.40% | 5.44% | 1.36% | 0.71% |
Return on Assets (ROA) | 3.07% | 2.41% | 3.31% | 0.21% | 0.32% | -1.68% |
Return on Invested Capital (ROIC) | 3.76% | 3.10% | 4.75% | 0.31% | 0.51% | -2.91% |
Return on Capital Employed (ROCE) | 4.86% | 3.95% | 4.12% | 0.23% | 0.42% | -1.47% |
Earnings Yield | 1.20% | 0.43% | 1.11% | 0.93% | 0.34% | 0.10% |
FCF Yield | 2.33% | 0.12% | 0.26% | 0.03% | 0.18% | - |
Buyback Yield / Dilution | 0.43% | 0.29% | -5.73% | -1.39% | -2.04% | -5.78% |
Total Shareholder Return | 0.43% | 0.29% | -5.73% | -1.39% | -2.04% | -5.78% |